Current:Home > MyEthermac|Snapchill canned coffee, sold across U.S., recalled due to botulism concerns -AssetLink
Ethermac|Snapchill canned coffee, sold across U.S., recalled due to botulism concerns
Surpassing Quant Think Tank Center View
Date:2025-04-08 13:42:03
Snapchill is recalling all of its cold cans of coffee sold by roasters nationwide because of concerns they could contain a potentially deadly toxin.
The products were manufactured in a way that "could lead to the growth and production of the deadly toxin, botulinum toxin, in low acid canned foods," the Green Bay, Wisconsin-based company said in a notice posted last week by the Food and Drug Administration.
Botulism is a rare but serious illness caused by the toxin that attacks the body's nerves, causing difficulty breathing, muscle paralysis and even death, according to the Centers for Disease Control and Prevention. Home-canned, preserved or fermented foods can provide the conditions to produce botulinum toxin. Those that consume such foods can become seriously ill or die if they don't get medical treatment quickly.
Symptoms include difficulty swallowing, muscle weakness, double vision, drooping eyelids, blurry vision, slurred speech, vomiting and diarrhea. Those that have such symptoms should go to an emergency room, the CDC said.
The company is not aware of any of its products containing the toxin, and no illnesses have been reported, according to Snapchill. The company became aware of the problem after being notified by the FDA that its process for manufacturing the recalled products had not been filed with the agency, as required. The company said it's working to file the notification.
The recall involves nearly 300 products sold under a variety of roaster and brand names, in metal cans ranging from 7 to 12 ounces. A complete list can be viewed here.
People who purchased the products should destroy them or return them for a refund.
Those with questions can email the company at [email protected], or call 920-632-6018 between 9 a.m. and 5 p.m. Eastern.
Kate GibsonKate Gibson is a reporter for CBS MoneyWatch in New York, where she covers business and consumer finance.
veryGood! (359)
Related
- IOC's decision to separate speed climbing from other disciplines paying off
- Indian rescuers prepare to drill to reach 40 workers trapped in a collapse tunnel since weekend
- Israel offers incubators for Gaza babies after Biden says hospitals must be protected
- Mother of boy who shot teacher gets 21 months in prison for using marijuana while owning gun
- Where will Elmo go? HBO moves away from 'Sesame Street'
- All The Only Ones: No More (Gender) Drama
- 8 teens arrested on murder charges in beating of classmate in Las Vegas
- Vatican plans to gradually replace car fleet with electric vehicles in deal with VW
- From bitter rivals to Olympic teammates, how Lebron and Steph Curry became friends
- Kevin Hart honored with Mark Twain Prize for lifetime achievement: It 'feels surreal'
Ranking
- Will the 'Yellowstone' finale be the last episode? What we know about Season 6, spinoffs
- A car struck a barricade near the Israeli Embassy in Tokyo. Police reportedly arrested the driver
- Russian court convicts a woman for protesting the war in Ukraine in latest crackdown on free speech
- New protests in Greece over Roma youth’s fatal shooting by police following car chase
- New Zealand official reverses visa refusal for US conservative influencer Candace Owens
- Pink gives away 2,000 banned books at Florida concerts
- Mississippi loosens its burn ban after more rain and less wildfires
- UK becomes 1st country to approve gene therapy treatment for sickle cell, thalassemia
Recommendation
Macy's says employee who allegedly hid $150 million in expenses had no major 'impact'
AP Election Brief | What to expect in Louisiana’s general election
13-year-old boy charged with killing father in DC, police say case was a domestic incident
UK becomes 1st country to approve gene therapy treatment for sickle cell, thalassemia
Costco membership growth 'robust,' even amid fee increase: What to know about earnings release
With a boost from John Oliver, pūteketeke soars to first in New Zealand bird contest
Fresh off meeting with China’s Xi, Biden is turning his attention to Asia-Pacific economies
JFK's E.R. doctors share new assassination details